Found: 11
Select item for more details and to access through your institution.
Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 7, p. 732, doi. 10.1002/ajh.23728
- By:
- Publication type:
- Article
Arsenic trioxide at conventional dosage does not aggravate hemorrhage in the first‐line treatment of adult acute promyelocytic leukemia.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 4, p. 344, doi. 10.1111/ejh.13018
- By:
- Publication type:
- Article
Deep learning based sequence detection with natural redundancy for memory sources.
- Published in:
- IET Communications (Wiley-Blackwell), 2023, v. 17, n. 9, p. 1140, doi. 10.1049/cmu2.12618
- By:
- Publication type:
- Article
Richness, not evenness, of invasive plant species promotes invasion success into native plant communities via selection effects.
- Published in:
- Oikos, 2022, v. 2022, n. 6, p. 1, doi. 10.1111/oik.08966
- By:
- Publication type:
- Article
Expanding Nilotinib Access in Clinical Trials (ENACT): an open-label, multicenter study of oral nilotinib in adult patients with imatinib-resistant or imatinib-intolerant Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Expanding Nilotinib Access in Clinical Trials (ENACT).
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 1, p. 118, doi. 10.1002/cncr.26249
- By:
- Publication type:
- Article
Efficacy, safety and pharmacokinetics of subcutaneous azacitidine in Chinese patients with higher risk myelodysplastic syndromes: Results from a multicenter, single-arm, open-label phase 2 study.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2018, v. 14, n. 3, p. 270, doi. 10.1111/ajco.12835
- By:
- Publication type:
- Article
Prognostic factors of Chinese patients with T/NK-cell lymphoma: a single institution study of 170 patients.
- Published in:
- Medical Oncology, 2012, v. 29, n. 3, p. 2176, doi. 10.1007/s12032-011-0011-0
- By:
- Publication type:
- Article
Loss of promoter methylation contributes to the expression of functionally impaired PRDM1β isoform in diffuse large B-cell lymphoma.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Elevated serum IL‐13 level is associated with increased Treg cells in tumor microenvironment and disease progression of diffuse large B‐cell lymphoma.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 2, p. 230, doi. 10.1002/hon.2993
- By:
- Publication type:
- Article
Reassessment of the prognostic factors of international prognostic index (IPI) in the patients with diffuse large B-cell lymphoma in an era of R-CHOP in Chinese population.
- Published in:
- Annals of Hematology, 2009, v. 88, n. 9, p. 863, doi. 10.1007/s00277-009-0702-1
- By:
- Publication type:
- Article